How do we improve patient compliance and adherence to long-term statin therapy?

Area of Science:

• Cardiology
• Pharmacology
• Public Health

Background:

• Statins are crucial for lowering LDL-cholesterol and reducing cardiovascular risk in millions.
• Patient adherence to statin therapy is essential for realizing clinical trial benefits in real-world settings.
• Statin discontinuation rates are high, with approximately 50% of patients stopping treatment within the first year.

Purpose of the Study:

• To explore patient perspectives on statin non-adherence.
• To identify key factors contributing to the discontinuation of statin therapy.
• To emphasize the importance of patient-provider dialogue in managing statin therapy.

Main Methods:

• Review of recent studies focusing on patient-reported reasons for non-adherence.
• Analysis of factors influencing patient adherence to long-term medication.
• Synthesis of evidence on the role of adverse events in treatment discontinuation.

Main Results:

• Adverse events are the primary reason cited by patients for discontinuing statin therapy.
• Patient, physician, and healthcare system factors all contribute to non-adherence.
• Adherence tends to decrease over time, exacerbating the problem.

Conclusions:

• Addressing patient concerns about adverse events through open dialogue is critical.
• Healthcare providers must actively engage patients to assess risks and benefits of continued statin use.
• Improving patient-physician communication can enhance statin adherence and cardiovascular outcomes.